US becomes first country to approve RSV vaccine
GSK's Arexvy green-lighted for adults aged 60 and older; similar shots from Pfizer and Moderna expected to follow soon.
· 11 months ago
Data do not support 4th Covid shot, say experts
Govt can expect pushback if it mandates second booster jab.
By Raevathi Supramaniam · 2 years ago
Visitors to recreational areas will be asked to leave if not fully vaccinated
Police keeping a close watch on SOP, says Bukit Aman deputy director.
· 2 years ago
US authorises booster jabs for those with weakened immune systems
Emergency use authorisation granted as nation struggles to contain Delta infections.
· 2 years ago
WTO fails anew to agree Covid vaccine patent rights waiver proposal
Member states will meet again to discuss ‘very emotional issue’.
· 2 years ago
820,000 Form One female students yet to receive HPV jab
Deputy minister says Covid-19 pandemic disrupted earlier delivery of vaccine.
· 6 months ago
GSK sues Pfizer over patents for RSV vaccine
British drugmaker claims American firm knowingly uses its inventions without permission.
· 8 months ago
Positive results for potential first chikungunya vaccine
Shot deemed 'generally safe,' with side effects similar to other jabs.
· 10 months ago
67 million children miss out on vaccines due to Covid
UN laments erosion of a decade of hard-earned gains in routine immunisation.
· 11 months ago
MOH to get new Covid-19 vaccine for elderly, kids with chronic diseases
Khairy Jamaluddin says jabs will be administered free of charge at government and private health facilities.
· 1 year ago
Enough supply of influenza vaccines, medical professionals say
Procurement from various sources to prevent shortage, The Star reports.
· 1 year ago
Don’t risk death, Sarawak leader tells yet-to-be vaccine-boosted folk
Uggah says there is ample proof third shot protects against Omicron.
By Desmond Davidson · 2 years ago